article

Paragon Bioservices Named to Deloitte’s Technology Fast 500

Baltimore Business Journal Ranks Paragon #8 on its Fast 50 Company List Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, today announced it was named to Deloitte’s Technology Fast 500™ for 2018, a ranking of the 500 fastest growing […]

Read More